<DOC>
	<DOC>NCT02220361</DOC>
	<brief_summary>Hemabate is often used for gynecological patients. Hemabate is associated with many side effects, including a burning sensation in the stomach, nausea, vomiting, diarrhea etc. It is reported that dexmedetomidine reduce gastrointestinal reaction during perioperative period. We design this clinical trial to find if dexmedetomidine can prevent the side effects of hemabate in Cesarean Section patients.</brief_summary>
	<brief_title>Dexmedetomidine on Prevention of Side Effects of Hemabate</brief_title>
	<detailed_description />
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Carboprost tromethamine</mesh_term>
	<mesh_term>Carboprost</mesh_term>
	<criteria>gynecological patients Neuromuscular and endocrine diseases Allergic reactions to a2adrenergic agonist Previous abdominal surgery including prior caesarean section.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>